Market Overview

A Look Into Sanofi's Debt

Share:

Over the past three months, shares of Sanofi (NASDAQ: SNY) moved lower by 7.99%. Before we understand the importance of debt, let us look at how much debt Sanofi has.

Sanofi's Debt

Based on Sanofi’s financial statement as of March 5, 2020, long-term debt is at $22.60 billion and current debt is at $5.11 billion, amounting to $27.71 billion in total debt. Adjusted for $10.58 billion in cash-equivalents, the company's net debt is at $17.13 billion.

Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents include cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents.

To understand the degree of financial leverage a company has, investors look at the debt ratio. Considering Sanofi’s $126.57 billion in total assets, the debt-ratio is at 0.22. As a rule of thumb, a debt-ratio more than one indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 25% might be higher for one industry and normal for another.

Why Investors Look At Debt?

Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives.

Interest-payment obligations can impact the cash-flow of the company. Equity owners can keep excess profit, generated from the debt capital, when companies use the debt capital for its business operations.

Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics - including debt-to-equity ratio. Click here to learn more.

A Look Into Sanofi's Debt

 

Related Articles (SNY)

View Comments and Join the Discussion!

Posted-In: Debt InsightsNews Intraday Update Markets